D. Corti and A. Lanzavecchia, Broadly neutralizing antiviral antibodies, Annual Review of Immunology, vol.31, issue.1, pp.705-742, 2013.
DOI : 10.1146/annurev-immunol-032712-095916

D. R. Burton and L. Hangartner, Broadly neutralizing antibodies to HIV and their role in vaccine design, Annual Review of Immunology, vol.34, issue.1, pp.635-659, 2016.
DOI : 10.1146/annurev-immunol-041015-055515
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034635

C. Moog, H. J. Fleury, I. Pellegrin, A. Kirn, and A. M. Aubertin, Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals, Journal of Virology, vol.71, issue.5, pp.3734-3741, 1997.

X. L. Wu, Z. Y. Yang, and Y. X. Li, Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1, Science, vol.329, issue.5993, pp.856-861, 2010.
DOI : 10.1126/science.1187659
URL : http://europepmc.org/articles/pmc2965066?pdf=render

T. Zhou, I. Georgiev, and X. Wu, Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01, Science, vol.329, issue.5993, pp.811-817, 2010.

I. Mikell, D. N. Sather, S. A. Kalams, M. Altfeld, G. Alter et al., Characteristics of the earliest crossneutralizing antibody response to HIV-1, PLoS Pathogens, vol.7, issue.1, p.1001251, 2011.

L. E. Mccoy and R. A. Weiss, Neutralizing antibodies to HIV-1 induced by immunization, Journal of Experimental Medicine, vol.210, issue.2, pp.209-223, 2013.

D. Peterhoff and R. Wagner, Guiding the long way to broad HIV neutralization, Current Opinion in HIV and AIDS, vol.12, issue.3, pp.257-264, 2017.
DOI : 10.1097/coh.0000000000000356

M. S. Cohen and L. Corey, Broadly neutralizing antibodies to prevent HIV-1, Science, vol.358, issue.6359, pp.46-47, 2017.
DOI : 10.1126/science.aap8131

J. R. Mascola, M. G. Lewis, and G. Stiegler, Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies, Journal of Virology, vol.73, issue.5, pp.4009-4018, 1999.

R. Shibata, T. Igarashi, and N. Haigwood, Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys, Nature Medicine, vol.5, issue.2, pp.204-210, 1999.

T. W. Baba, V. Liska, and R. Hofmann-lehmann, Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection, Nature Medicine, vol.6, issue.2, pp.200-206, 2000.

P. W. Parren, P. A. Marx, and A. J. Hessell, Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro, Journal of Virology, vol.75, issue.17, pp.8340-8347, 2001.

F. Ferrantelli, R. Hofmann-lehmann, and R. A. Rasmussen, Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques, AIDS, vol.17, issue.3, pp.301-309, 2003.
DOI : 10.1097/00002030-200302140-00003

S. Nakowitsch, H. Quendler, H. Fekete, R. Kunert, H. Katinger et al., HIV-1 mutants escaping neutralization by the human antibodies 2F5, 2G12, and 4E10: in vitro experiments versus clinical studies, AIDS, vol.19, issue.17, pp.1957-1966, 2005.
DOI : 10.1097/01.aids.0000189856.13817.76

A. Trkola, H. Kuster, and P. Rusert, Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies, Nature Medicine, vol.11, issue.6, pp.615-622, 2005.

R. M. Ruprecht, Passive immunization with human neutralizing monoclonal antibodies against HIV-1 in macaque models: experimental approaches, Methods in Molecular Biology, vol.525, pp.559-566, 2009.
DOI : 10.1007/978-1-59745-554-1_31

A. J. Hessell, P. Poignard, and M. Hunter, Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques, Nature Medicine, vol.15, issue.8, pp.951-954, 2009.
DOI : 10.1038/nm.1974
URL : http://europepmc.org/articles/pmc4334439?pdf=render

J. F. Scheid, H. Mouquet, and N. Feldhahn, Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals, Nature, vol.458, issue.7238, pp.636-640, 2009.

G. Frey, J. Chen, S. Rits-volloch, M. M. Freeman, S. Zolla-pazner et al., Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and nonneutralizing antibodies, Nature Structural & Molecular Biology, vol.17, issue.12, pp.1486-1491, 2010.
DOI : 10.1038/nsmb.1950
URL : http://europepmc.org/articles/pmc2997185?pdf=render

R. Kong, K. Xu, and T. Zhou, Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody, Science, vol.352, issue.6287, pp.828-833, 2016.

G. Stiegler, R. Kunert, and M. Purtscher, A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1, AIDS Research and Human Retroviruses, vol.17, issue.18, pp.1757-1765, 2001.

A. Manrique, P. Rusert, and B. Joos, In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10, Journal of Virology, vol.81, issue.16, pp.8793-8808, 2007.
DOI : 10.1128/jvi.00598-07
URL : http://europepmc.org/articles/pmc1951363?pdf=render

K. Xu, P. Acharya, and R. Kong, Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1, Nature Medicine, vol.24, issue.6, pp.857-867, 2018.

O. Ringel, V. Vieillard, P. Debré, J. Eichler, H. Büning et al., The hard way towards an antibody-based HIV-1 Env vaccine: lessons from other viruses, Viruses, vol.10, issue.4, 2018.
DOI : 10.3390/v10040197
URL : https://hal.archives-ouvertes.fr/hal-01780137

M. Montero, N. E. Van-houten, X. Wang, and J. K. Scott, The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design, Microbiology and Molecular Biology Reviews, vol.72, issue.1, pp.54-84, 2008.

L. Scharf, J. F. Scheid, and J. H. Lee, Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike, Cell Reports, vol.7, issue.3, pp.785-795, 2014.

V. Vieillard, J. L. Strominger, and P. Debré, NK cytotoxicity against CD4

, + T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand, Proceedings of the National Academy of Sciences of the United States of America, vol.102, pp.10981-10986, 2005.

V. Vieillard, S. Gharakhanian, and O. Lucar, Perspectives for immunotherapy: which applications might achieve an HIV functional cure?, Oncotarget, vol.7, issue.25, pp.38946-38958, 2016.
DOI : 10.18632/oncotarget.7793
URL : https://hal.archives-ouvertes.fr/hal-01285657

V. Vieillard, R. E. Habib, and P. Brochard, CCR5 or CXCR4 use influences the relationship between CD4 cell depletion, NKp44L expression and NK cytotoxicity in SHIV-infected macaques, AIDS, vol.22, issue.2, pp.185-192, 2008.
DOI : 10.1097/qad.0b013e3282f35551

V. Vieillard, N. Dereuddre-bosquet, I. Mangeot-méderlé, R. L. Grand, and P. Debré, An HIVgp41 vaccine protects CD4 central memory T cells in SHIV-infected macaques, Vaccine, vol.30, issue.48, pp.6883-6891, 2012.
DOI : 10.1016/j.vaccine.2012.09.004

C. Petitdemange, A. Achour, and S. Dispinseri, A single amino-acid change in a highly conserved motif of gp41 elicits HIV-1 neutralization and protects against CD4 depletion, Clinical Infectious Diseases, vol.57, issue.5, pp.745-755, 2013.

T. Bradley, A. Trama, and N. Tumba, Amino acid changes in the HIV-1 gp41 membrane proximal region control virus neutralization sensitivity, vol.12, pp.196-207, 2016.

O. Lucar, B. Su, and V. Potard, Neutralizing antibodies against a specific human immunodeficiency virus gp41 epitope are associated with long-term non-progressor status, vol.22, pp.122-132, 2017.
DOI : 10.1016/j.ebiom.2017.07.007
URL : https://hal.archives-ouvertes.fr/hal-01599388

M. Pancera, T. Zhou, and A. Druz, Structure and immune recognition of trimeric pre-fusion HIV-1 Env, Nature, vol.514, issue.7523, pp.455-461, 2014.

J. H. Lee, G. Ozorowski, and A. B. Ward, Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer, Science, vol.351, issue.6277, pp.1043-1048, 2016.

I. Fisch, R. E. Kontermann, and R. Finnern, A strategy of exon shuffling for making large peptide repertoires displayed on filamentous bacteriophage, Proceedings of the National Academy of Sciences of the United States of America, vol.93, pp.7761-7766, 1996.

K. Dorgham, I. Dogan, and N. Bitton, Immunogenicity of HIV type 1 gp120 CD4 binding site phage mimotopes, AIDS Research and Human Retroviruses, vol.21, issue.1, pp.82-92, 2005.

L. J. Harris, E. Skaletsky, and A. Mcpherson, Crystallographic structure of an intact IgG1 monoclonal antibody, Journal of Molecular Biology, vol.275, issue.5, pp.861-872, 1998.
DOI : 10.1006/jmbi.1997.1508

J. Maupetit, P. Derreumaux, and P. Tuffery, PEP-FOLD: an online resource for de novo peptide structure prediction, Nucleic Acids Research, vol.37, issue.2, pp.498-503, 2009.
DOI : 10.1093/nar/gkp323
URL : https://academic.oup.com/nar/article-pdf/37/suppl_2/W498/3925007/gkp323.pdf

R. Chen and Z. Weng, A novel shape complementarity scoring function for protein-protein docking, Proteins: Structure, Function, and Genetics, vol.51, issue.3, pp.397-408, 2003.
DOI : 10.1002/prot.10334

O. Elemento and M. P. Lefranc, IMGT/PhyloGene: an on-line tool for comparative analysis of immunoglobulin and T cell receptor genes, Developmental & Comparative Immunology, vol.27, issue.9, pp.763-779, 2003.

G. Pialoux, J. L. Excler, and Y. Rivière, A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI), AIDS Research and Human Retroviruses, vol.11, issue.3, pp.373-381, 1995.

S. Delhalle, J. C. Schmit, and A. Chevigne, Phages and HIV-1: from display to interplay, International Journal of Molecular Sciences, vol.13, issue.4, pp.4727-4794, 2012.
DOI : 10.3390/ijms13044727
URL : http://www.mdpi.com/1422-0067/13/4/4727/pdf

D. R. Burton and J. R. Mascola, Antibody responses to envelope glycoproteins in HIV-1 infection, Nature Immunology, vol.16, issue.6, pp.571-576, 2015.
DOI : 10.1038/ni.3158
URL : http://europepmc.org/articles/pmc4834917?pdf=render

A. Escolano, J. M. Steichen, and P. Dosenovic, Sequential immunization elicits broadly neutralizing anti-HIV-1 antibodies in Ig knockin mice, Cell, vol.166, issue.6, pp.1445-1458, 2016.
DOI : 10.1016/j.cell.2016.07.030
URL : http://europepmc.org/articles/pmc5019122?pdf=render

P. D. Kwong and J. R. Mascola, HIV-1 vaccines based on antibody identification, B cell ontogeny, and epitope structure, Immunity, vol.48, issue.5, pp.855-871, 2018.
DOI : 10.1016/j.immuni.2018.04.029

A. Trkola, A. B. Pomales, and H. Yuan, Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG, Journal of Virology, vol.69, issue.11, pp.6609-6617, 1995.

M. B. Zwick, R. Jensen, and S. Church, Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membraneproximal external region of glycoprotein gp41 to neutralize HIV-1, Journal of Virology, vol.79, issue.2, pp.1252-1261, 2004.

T. C. Vancott, F. R. Bethke, and V. R. Polonis, Dissociation rate of antibody-gp120 binding interactions is predictive of V3-mediated neutralization of HIV-1, Journal of Immunology, vol.153, issue.1, pp.449-459, 1994.

R. Wyatt and J. Sodroski, The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens, Science, vol.280, issue.5371, pp.1884-1888, 1998.
DOI : 10.1126/science.280.5371.1884

A. F. Labrijn, P. Poignard, and A. Raja, Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1, Journal of Virology, vol.77, issue.19, pp.10557-10565, 2003.

M. Kim, Z. Y. Sun, and K. D. Rand, Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization, Nature Structural & Molecular Biology, vol.18, issue.11, pp.1235-1243, 2011.
DOI : 10.1038/nsmb.2154
URL : http://europepmc.org/articles/pmc3253551?pdf=render

J. M. Kovacs, E. Noeldeke, and H. J. Ha, Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure, Proceedings of the National Academy of Sciences of the United States of America, vol.111, pp.18542-18547, 2014.
DOI : 10.1073/pnas.1422269112
URL : http://www.pnas.org/content/111/52/18542.full.pdf

P. D. Kwong and J. R. Mascola, Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies, Immunity, vol.37, issue.3, pp.412-425, 2012.
DOI : 10.1016/j.immuni.2012.08.012
URL : https://doi.org/10.1016/j.immuni.2012.08.012

J. R. Mascola and B. F. Haynes, HIV-1 neutralizing antibodies: understanding nature's pathways, Immunological Reviews, vol.254, issue.1, pp.225-244, 2013.
DOI : 10.1111/imr.12075
URL : http://europepmc.org/articles/pmc3738265?pdf=render

R. A. Pantophlet, Antibody epitope exposure and neutralization of HIV-1, Current Pharmaceutical Design, vol.16, issue.33, pp.3729-3743, 2010.

K. B. Jensen, M. Larsen, and J. S. Pedersen, Functional improvement of antibody fragments using a novel phage coat protein III fusion system, Biochemical and Biophysical Research Communications, vol.298, issue.4, pp.566-573, 2002.

L. Aghebati-maleki, B. Bakhshinejad, and B. Baradaran, Phage display as a promising approach for vaccine development, Journal of Biomedical Science, vol.23, issue.1, p.66, 2016.
DOI : 10.1186/s12929-016-0285-9
URL : https://jbiomedsci.biomedcentral.com/track/pdf/10.1186/s12929-016-0285-9

A. Prisco and P. Berardinis, Filamentous bacteriophage Fd as an antigen delivery system in vaccination, International Journal of Molecular Sciences, vol.13, issue.4, pp.5179-5194, 2012.
DOI : 10.3390/ijms13045179
URL : http://www.mdpi.com/1422-0067/13/4/5179/pdf

R. Krishnan, H. Tsubery, and M. Y. Proschitsky, A bacteriophage capsid protein provides a general amyloid interaction motif (GAIM) that binds and remodels misfolded protein assemblies, Journal of Immunology Research, vol.426, issue.13, pp.2500-2519, 2014.
DOI : 10.1016/j.jmb.2014.04.015